These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
140 related articles for article (PubMed ID: 32713191)
1. A Case of Successful Allogeneic Hematopoietic Stem Cell Transplantation for HHV8-Positive Castleman's Disease with a Review of the Literature. Wang Z; Yang S; Zhu Z; Lei P; Yang J; Zhang P; Sun K Cell Transplant; 2020; 29():963689720943571. PubMed ID: 32713191 [TBL] [Abstract][Full Text] [Related]
2. [Two HHV8-related illnesses in a HIV-negative patient: Kaposi's sarcoma and multicentric Castleman's disease. Response to treatment with Rituximab and CHOP]. Pastor MA; Vasco B; Mosquera JM; Debén G; Bautista P; Requena L Actas Dermosifiliogr; 2006; 97(6):385-90. PubMed ID: 16956518 [TBL] [Abstract][Full Text] [Related]
3. HHV8-positive, HIV-negative multicentric Castleman's disease: early and sustained complete remission with rituximab therapy without reactivation of Kaposi sarcoma. Nicoli P; Familiari U; Bosa M; Allice T; Mete F; Morotti A; Cilloni D; Saglio G; Guerrasio A Int J Hematol; 2009 Oct; 90(3):392-396. PubMed ID: 19756920 [TBL] [Abstract][Full Text] [Related]
4. Concomitant Kaposi sarcoma and multicentric Castleman's disease in a heart transplant recipient. Patel A; Bishburg E; Zucker M; Tsang P; Nagarakanti S; Sabnani I Heart Lung; 2014; 43(6):506-9. PubMed ID: 25169666 [TBL] [Abstract][Full Text] [Related]
5. Multicentric Castleman's disease in India - Does EBV rather than HHV8 play a role? Bhanvadia V; Shet T; Rao V; Epari S; Gujral S; Jain H; Bagal B; Sengar M Indian J Pathol Microbiol; 2021; 64(2):302-309. PubMed ID: 33851624 [TBL] [Abstract][Full Text] [Related]
6. [Treatment of Gaucher disease with allogeneic hematopoietic stem cell transplantation: report of three cases and review of literatures]. Tang X; Luan Z; Wu N; Zhang B; Jing Y; Du H; Lu W; Xu S Zhonghua Er Ke Za Zhi; 2015 Nov; 53(11):810-6. PubMed ID: 26758318 [TBL] [Abstract][Full Text] [Related]
7. Allogeneic hematopoietic cell transplantation without myeloablative conditioning for patients with advanced hematologic malignancies. Gürman G; Arat M; Ilhan O; Konuk N; Beksaç M; Celebi H; Ozcan M; Arslan O; Ustün C; Akan H; Uysal A; Koç H Cytotherapy; 2001; 3(4):253-60. PubMed ID: 12171713 [TBL] [Abstract][Full Text] [Related]
8. [Allogeneic hematopoietic stem cell transplantation for high-risk acute leukemia]. Wang Y; Liu KY; Xu LP; Liu DH; Chen H; Han W; Chen YH; Shi HX; Zhang YC; Wang JZ; Zhang XU; Chen Y; Huang XJ; Lu DP Zhonghua Nei Ke Za Zhi; 2007 Nov; 46(11):903-6. PubMed ID: 18261271 [TBL] [Abstract][Full Text] [Related]
9. Fifty years of multicentric Castleman's disease. Waterston A; Bower M Acta Oncol; 2004; 43(8):698-704. PubMed ID: 15764213 [TBL] [Abstract][Full Text] [Related]
10. [Outcome of allogeneic hematopoietic stem cell transplantation from HLA-matched sibling donor for 41 cases of severe aplastic anemia]. Chen X; Wei JL; Huang Y; He Y; Yang DL; Jiang EL; Ma QL; Zhou LK; Lin XT; Shen YY; Feng SZ; Han MZ Zhonghua Xue Ye Xue Za Zhi; 2012 Aug; 33(8):610-4. PubMed ID: 23134851 [TBL] [Abstract][Full Text] [Related]
11. [Fludarabine-based increased-intensity conditioning regimen for allogeneic hematopoietic stem cell transplantation in acquired severe aplastic anemia]. Sun C; Lin X; Huang Y; Song C; Tao Y; Tu S; Fang J; Chen T; Sun C; Wu B Zhonghua Xue Ye Xue Za Zhi; 2014 Mar; 35(3):221-4. PubMed ID: 24666488 [TBL] [Abstract][Full Text] [Related]
12. [Clinical study of allogeneic hematopoietic stem cell transplantation for relapsed/refractory acute lymphocytic leukemia]. Ma X; Wu DP; Sun AN; Fu ZZ; Tang XW; Wu XJ; Liu YJ; Qiu HY; Miao M; Han Y; Jin ZM; Zhao Y; Xue SL; Wang Y; Chen SN; He GS; Zhou HX; Chang HR Zhonghua Xue Ye Xue Za Zhi; 2009 Feb; 30(2):73-6. PubMed ID: 19563014 [TBL] [Abstract][Full Text] [Related]
13. [Salvage Trerapy for Patients with Relapsed and Refractory Lymphoma by Allogeneic Hematopoietic Stem Cell Transplantation]. Yin Y; Qiu ZX; Li Y; Xu WL; Sun YH; Liu W; Wang WS; Wang MJ; Wang LH; Dong YJ; Ou JP; Cen XN; Ren HY Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2017 Apr; 25(2):418-425. PubMed ID: 28446286 [TBL] [Abstract][Full Text] [Related]
14. Increased expression of vascular endothelial growth factor (VEGF) in Castleman's disease: proposed pathomechanism of vascular proliferation in the affected lymph node. Nishi J; Maruyama I Leuk Lymphoma; 2000 Jul; 38(3-4):387-94. PubMed ID: 10830746 [TBL] [Abstract][Full Text] [Related]
15. [Comparison of intensified myeloablative conditioning regime without antithymocytic globulin (ATG) with myeloablative conditioning regime for single-unit unrelated umbilical cord blood transplantation in hematological malignancies]. Sun ZM; Liu HL; Wu Y; Geng LQ; Zheng CC; Tang BL; Zhu XY; Tong J; Wang XB; Ding KY; Wan X; Zhang L; Yao W; Zhang XH; Han YS; Yang HZ; Liu X; Zhu WW; Wu JS; Wang ZY Zhonghua Yi Xue Za Zhi; 2016 Jul; 96(28):2214-9. PubMed ID: 27480651 [TBL] [Abstract][Full Text] [Related]
16. [Liver biopsy in the management of liver dysfunction after allogeneic hematopoietic stem-cell transplantation]. Chen H; Huang XJ; Liu KY; Xu LP; Wang H; Liu DH; Lu J; Lu DP Zhonghua Yi Xue Za Zhi; 2005 Nov; 85(43):3062-6. PubMed ID: 16324408 [TBL] [Abstract][Full Text] [Related]
17. Comparable outcomes among unmanipulated haploidentical, matched unrelated, and matched sibling donors in BU-based myeloablative hematopoietic stem cell transplantation for intermediate and adverse risk acute myeloid leukemia in complete remission: a single-center study. Lu Y; Zhao YL; Zhang JP; Xiong M; Cao XY; Liu DY; Sun RJ; Wei ZJ; Zhou JR; Lu DP Ann Hematol; 2021 Jun; 100(6):1579-1591. PubMed ID: 33236196 [TBL] [Abstract][Full Text] [Related]
18. Idiopathic multicentric Castleman's disease: a systematic literature review. Liu AY; Nabel CS; Finkelman BS; Ruth JR; Kurzrock R; van Rhee F; Krymskaya VP; Kelleher D; Rubenstein AH; Fajgenbaum DC Lancet Haematol; 2016 Apr; 3(4):e163-75. PubMed ID: 27063975 [TBL] [Abstract][Full Text] [Related]
19. [Allogeneic hematopoietic stem cell transplantation for hemophagocytic syndrome]. Sun R; Xiao J; Zhang J; Lu Y; Wei Z; Zhu H; Sun Y Zhonghua Er Ke Za Zhi; 2014 Feb; 52(2):94-8. PubMed ID: 24739718 [TBL] [Abstract][Full Text] [Related]
20. [Mycophenolate mofetil in treatment of graft-versus-host disease after allogeneic hematopoietic cell transplantation: analysis of 44 cases]. Chen H; Liu KY; Liu DH; Xu LP; Han W; Chen YH; Huang XJ Zhonghua Yi Xue Za Zhi; 2008 Aug; 88(30):2127-30. PubMed ID: 19080474 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]